ENDONOVO THERAPEUTICS, INC. Quarterly Entity Common Stock, Shares Outstanding from Q1 2012 to Q4 2023

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Endonovo Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q1 2012 to Q4 2023.
  • Endonovo Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending December 28, 2023 was 319M shares, a 64% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 319M +124M +64% Dec 28, 2023 10-Q/A 2023-12-29
Q3 2023 318M +165M +108% Aug 21, 2023 10-Q 2023-08-21
Q2 2023 282M +141M +100% May 19, 2023 10-Q 2023-05-22
Q1 2023 270M +121M +80.8% Apr 17, 2023 10-K 2023-04-17
Q4 2022 194M +122M +170% Nov 18, 2022 10-Q 2022-11-21
Q3 2022 152M +86.7M +132% Aug 19, 2022 10-Q 2022-08-22
Q2 2022 141M +80.2M +133% May 19, 2022 10-Q 2022-05-19
Q1 2022 150M +96M +179% Apr 13, 2022 10-K 2022-04-14
Q4 2021 72M +53M +280% Nov 19, 2021 10-Q 2021-11-19
Q3 2021 65.8M +49.5M +304% Aug 20, 2021 10-Q 2021-08-23
Q2 2021 60.5M +50M +476% May 17, 2021 10-Q 2021-05-24
Q1 2021 53.6M +44.8M +508% Apr 13, 2021 10-K 2021-04-13
Q4 2020 19M -912M -98% Nov 19, 2020 10-Q 2020-11-19
Q3 2020 16.3M Aug 18, 2020 10-Q 2020-08-19
Q2 2020 10.5M -750M -98.6% Jun 11, 2020 10-Q 2020-06-12
Q1 2020 8.81M -520M -98.3% May 1, 2020 10-K 2020-05-04
Q4 2019 931M Nov 19, 2019 10-Q 2019-11-19
Q2 2019 761M +395M +108% Aug 13, 2019 10-Q 2019-08-13
Q1 2019 529M +188M +55% Apr 15, 2019 10-K 2019-04-15
Q3 2018 395M +89.9M +29.4% Nov 8, 2018 10-Q 2018-11-13
Q2 2018 366M +104M +39.7% Aug 13, 2018 10-Q 2018-08-13
Q1 2018 341M +120M +54.1% Apr 6, 2018 10-K 2018-04-06
Q3 2017 305M +178M +140% Nov 3, 2017 10-Q/A 2017-11-09
Q2 2017 262M +152M +139% Aug 9, 2017 10-Q 2017-08-10
Q1 2017 222M +114M +105% Apr 13, 2017 10-K 2017-04-17
Q3 2016 127M +26M +25.6% Nov 11, 2016 10-Q 2016-11-14
Q2 2016 110M +10.8M +11% May 20, 2016 10-Q/A 2016-05-27
Q1 2016 108M Mar 24, 2016 10-K/A 2016-05-17
Q4 2015 103M Nov 20, 2015 10-Q 2015-11-23
Q3 2015 101M Aug 17, 2015 10-Q 2015-08-19
Q2 2015 98.8M Jun 15, 2015 10-Q/A 2015-06-15
Q4 2013 80.2M +27.5M +52.3% Dec 15, 2013 10-Q 2013-12-18
Q3 2013 70.9M +20.3M +40% Aug 19, 2013 10-Q/A 2013-08-28
Q2 2013 68.6M +20M +41.3% May 17, 2013 10-Q/A 2013-06-21
Q1 2013 66.4M +20M +43% Apr 16, 2013 10-K/A 2013-05-03
Q4 2012 52.7M Nov 29, 2012 10-Q 2012-11-29
Q3 2012 50.7M Aug 20, 2012 10-Q 2012-08-20
Q2 2012 48.5M May 21, 2012 10-Q 2012-05-21
Q1 2012 46.4M Apr 12, 2012 10-K 2012-04-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.